What if the price of your usual medications suddenly went from €0 to several euros, even with a prescription? This is the unpleasant surprise announced for early 2026: several widely used treatments will soon no longer be fully reimbursed, including for patients with long-term conditions (ALD). A decision that has sparked numerous reactions, and which could impact the daily lives of thousands of French people.
A saving… at the expense of patients?
To understand this development, we must return to a target: €5.5 billion in savings is the amount that the Health Insurance aims to achieve by 2026. Among the measures envisaged, one of them is particularly controversial: the partial delisting of medications considered to have a “low medical service rendered.”
From February 1, 2026, everyday medications will no longer be reimbursed by health insurance: the French will have to pay for them out of pocket.
